Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.
Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, Parkkinen J, Aggarwal BB. Yadav VR, et al. Among authors: kannappan r. Biochem Pharmacol. 2010 Oct 1;80(7):1021-32. doi: 10.1016/j.bcp.2010.06.022. Epub 2010 Jun 23. Biochem Pharmacol. 2010. Retraction in: Biochem Pharmacol. 2016 Feb 15;102:142. doi: 10.1016/j.bcp.2015.11.007. PMID: 20599780 Free PMC article. Retracted.
Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.
Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, Kim JH, Gupta SC, Phromnoi K, Sundaram C, Prasad S, Chaturvedi MM, Sung B. Aggarwal BB, et al. Among authors: kannappan r. Curr Drug Targets. 2011 Oct;12(11):1595-653. doi: 10.2174/138945011798109464. Curr Drug Targets. 2011. PMID: 21561421 Free PMC article.
Retraction notice to “Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake” [Biochem. Pharmacol. 80 (2010) 1021–1032].
Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, Parkkinen J, Aggarwal BB. Yadav VR, et al. Among authors: kannappan r. Biochem Pharmacol. 2016 Feb 15;102:142. doi: 10.1016/j.bcp.2015.11.007. Epub 2016 Feb 20. Biochem Pharmacol. 2016. PMID: 26985464 Free PMC article. No abstract available.
NF-κB addiction and its role in cancer: 'one size does not fit all'.
Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. Chaturvedi MM, et al. Among authors: kannappan r. Oncogene. 2011 Apr 7;30(14):1615-30. doi: 10.1038/onc.2010.566. Epub 2010 Dec 20. Oncogene. 2011. PMID: 21170083 Free PMC article. Review.
Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.
Reuter S, Prasad S, Phromnoi K, Kannappan R, Yadav VR, Aggarwal BB. Reuter S, et al. Among authors: kannappan r. Mol Cancer Res. 2010 Oct;8(10):1425-36. doi: 10.1158/1541-7786.MCR-10-0141. Epub 2010 Sep 8. Mol Cancer Res. 2010. Retraction in: Mol Cancer Res. 2018 Sep;16(9):1443. doi: 10.1158/1541-7786.MCR-18-0818. PMID: 20826545 Free PMC article. Retracted.
63 results